Markets

Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide. Through this partnership, Medisca will…

Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that Curtis Rambaran, MD, Chief Medical Officer of Silence Therapeutics, will participate…

End-to-end platform eliminates water as a constraint to data center growth, replacing legacy, fragmented approaches with a fully integrated infrastructure solution.

KBRA UK (KBRA) assigns preliminary ratings to six classes of notes issued by Bletchley Park Funding 2026-1 PLC, a static UK RMBS securitisation backed by a portfolio of first-ranking buy-to-let…

GenNx360 Capital Partners (“GenNx360”), a New York-based private equity firm, has announced the sale of its portfolio company, Precision Aviation Group, Inc. (“PAG” or the “Company”), to VSE Corporation (“VSE”)…

– LUMRYZ Met All Primary and Key Secondary Endpoints Demonstrating Statistically Significant and Clinically Meaningful Improvements Compared to Placebo in Excessive Daytime Sleepiness and Patient-Reported Disease Severity – – Safety…

The largest corporate bond issuance from the region attracted nearly USD 14 billion in demand from around 300 global institutional investors, marking a milestone moment for Southeast European capital markets.

Transaction Accelerates FGI’s Growth and Expands Product Offering

Step-Change Decisions Are Increasing in Scale, Frequency and Complexity but Are Being Made ‘In the Dark’, New Kallikor Research Finds 9 in 10 leaders expect to deliver at least one…

The screen-free, research-backed approach provides children with a stronger foundation needed to support one of the most important early academic skills.